Literature DB >> 3209562

Carotid baroreflex responsiveness in high-fit and sedentary young men.

J A Barney1, T J Ebert, L Groban, P A Farrell, C V Hughes, J J Smith.   

Abstract

The influence of fitness on cardiac vagal activity and baroreflex-mediated control of heart rate has not been clearly established in humans. Therefore, we studied resting cardiac vagal activity by evaluating respiratory sinus arrhythmia (RSA) and examined carotid-cardiac baroreflex responsiveness with a neck collar in 11 high-fit and 9 sedentary [based on maximal O2 consumption (VO2max) and history of physical activity] healthy young men (19-31 yr of age). Resting cardiac vagal activity was determined from the standard deviation of 100 consecutive resting R-R intervals. Baroreflex responsiveness was determined from the R-R interval responses to neck suction and pressure (repeated trials of 5-s stimuli of -20, -40, and 35 mmHg). Both RSA and the bradycardic (R-R interval) responses to neck suction of -40 mmHg were significantly greater (P less than 0.05) in the high-fit individuals (RSA, 116.5 +/- 11.5 ms; neck-suction response, 145.3 +/- 17.0 ms; mean +/- SE) compared with sedentary subjects (RSA, 65.2 +/- 6.6 ms; neck-suction response, 86.9 +/- 12.5 ms). Responses of the high-fit volunteers to the other intensities of neck stimuli (-20 and 35 mmHg) showed a similar trend but were not significantly different from those of the sedentary volunteers. The baroreflex slope derived from these data was significantly greater in the high-fit subjects (4.00 +/- 0.39 ms/mmHg) compared with the sedentary controls (2.53 +/- 0.28 ms/mmHg). These data suggest that resting cardiac vagal activity is greater, carotid-to-cardiac activity is well maintained, and baroreflex sensitivity, i.e., slope, is augmented in high-fit subjects.

Entities:  

Mesh:

Year:  1988        PMID: 3209562     DOI: 10.1152/jappl.1988.65.5.2190

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

1.  The effects of autonomic dysfunction and endurance training on cardiovascular control.

Authors:  J M Wecht; R E De Meersman; J P Weir; A M Spungen; W A Bauman; D R Grimm
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

2.  Respiratory sinus arrhythmia alteration following training in endurance athletes.

Authors:  R E De Meersman
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

3.  Seasonal training and heart rate and blood pressure variabilities in young swimmers.

Authors:  Renza Perini; Adelaide Tironi; Michela Cautero; Antonio Di Nino; Enrico Tam; Carlo Capelli
Journal:  Eur J Appl Physiol       Date:  2006-04-25       Impact factor: 3.078

4.  Heart rate variability in smokers, sedentary and aerobically fit individuals.

Authors:  D Gallagher; T Terenzi; R de Meersman
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

5.  Heart rate recovery after exercise and neural regulation of heart rate variability in 30-40 year old female marathon runners.

Authors:  Na Du; Siqin Bai; Kazuo Oguri; Yoshihiro Kato; Ichie Matsumoto; Harumi Kawase; Toshio Matsuoka
Journal:  J Sports Sci Med       Date:  2005-03-01       Impact factor: 2.988

Review 6.  Health promotion and exercise training.

Authors:  A Viru; T Smirnova
Journal:  Sports Med       Date:  1995-02       Impact factor: 11.136

7.  Vascular and baroreceptor abnormalities in young males with a family history of hypertension.

Authors:  Yati N Boutcher; Young J Park; Stephen H Boutcher
Journal:  Eur J Appl Physiol       Date:  2009-08-28       Impact factor: 3.078

Review 8.  The 'athletic heart syndrome'. A critical review.

Authors:  K P George; L A Wolfe; G W Burggraf
Journal:  Sports Med       Date:  1991-05       Impact factor: 11.136

9.  Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study.

Authors:  Scott C Adams; Ronald Schondorf; Julie Benoit; Robert D Kilgour
Journal:  BMC Cancer       Date:  2015-05-18       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.